Skip to main content

Day: January 7, 2022

Energem Corp. Announces Separate Trading of its Common Stock and Warrants, Commencing January 10, 2022

Kuala Lumpur, Malaysia, Jan. 07, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Energem Corp. (the “Company”) today announced that commencing January 10, 2022, holders of the units sold in the Company’s initial public offering may elect to separately trade the shares of common stock and warrants included in the units on The Nasdaq Global Market (“Nasdaq”). Each unit consists of one share of common stock, par value $0.0001 per share and one warrant, with each whole warrant entitling the holder to purchase one share of common stock at a price of $11.50 per share.  No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The shares of common stock and warrants that are separated will trade on the Nasdaq under the symbols “ENCP” and “ENCPW,” respectively.  Those...

Continue reading

Coherus BioSciences Secures Credit Financing with Pharmakon Advisors

Balance sheet strengthened to support commercial launches of as many as five new products in 2022 and 2023 REDWOOD CITY, Calif., Jan. 07, 2022 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (Coherus or the Company) (Nasdaq: CHRS) today announced that it has entered into a loan agreement with investment funds managed by Pharmakon Advisors, LP. “As Coherus enters a period of projected significant topline growth and diversification of our commercial product portfolio, we are pleased to partner with Pharmakon on this new credit facility,” said Denny Lanfear, President and CEO of Coherus. “Strengthening our balance sheet with non-dilutive capital will allow us to maximize shareholder value as we launch as many as five new products in 2022 and 2023.” The credit facility provides Coherus with up to $300 million committed across four tranches,...

Continue reading

USA Equities Corp’s QHSLab Digital Health Platform Strategy is Backed by Latest Research Published in the Journal of the American Medical Association (JAMA)

The JAMA research found that digital health interventions supporting patient self-management improves primary care for patients with multiple chronic conditions. QHSLab supports medical decision making in the management of many chronic conditions including in patients with multimorbidity’s. Independent physicians increasingly rely upon digital health systems to provide solutions that address their patient’s problems but are not happy with single disease specific vendor relationship.West Palm Beach, FL, Jan. 07, 2022 (GLOBE NEWSWIRE) — USA Equities Corp. (OTCQB: USAQ), a company focused on providing clinicians with tools to leverage proactive value-based healthcare solutions through the use of emerging digital and point of care technologies, recently found additional scientific validation for its digital medicine platform —...

Continue reading

2022 – A Year of Growth for Novo Resources

VANCOUVER, British Columbia, Jan. 07, 2022 (GLOBE NEWSWIRE) — Dear Shareholders, 2021 was a transformative year for Novo Resources as we moved from being an explorer to an explorer and producer. With the acquisition and refurbishment of the Golden Eagle processing facility in 2020, we were able to bring the Beatons Creek conglomerate gold project into production in early 2021. As we safely transitioned to operations, we also refreshed the Board with a primary focus to diversify our corporate, operations, development and ESG experience. We were very pleased to add Ross Hamilton, Amy Jo Stefonick and Mike Spreadborough to the Board, whilst Yoshikazu Ishikawa and long-term director Akiko Levinson departed. Mike Spreadborough then moved to the role of Executive Co-Chairman with Quinton Hennigh transitioning to Non-executive Co-Chairman....

Continue reading

Medigus: Eventer Technologies Ltd. Submitted Confidential Draft Registration Statement for the Proposed U.S. Initial Public Offering

Tel Aviv, Israel, Jan. 07, 2022 (GLOBE NEWSWIRE) — Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced that its 47.69% owned subsidiary, Eventer Technologies Ltd. ( “Eventer”), software company engaged in the development and operation of a technology platform, based on cloud computing, for the management of ticketing sales for in-person, virtual (events which occur and are broadcast over a digital platform over the internet), and hybrid events (events that allow both in-person and virtual participation) of various types, including performances, festivals, courses, lectures, conferences and different activities, confidentially submitted a draft registration statement on Form F-1 to the U.S. Securities and...

Continue reading

Branded Legacy, Inc.’s Spikes CBDX Opens New Retail Account

The Company Adds Three New Regional Managers Orlando, FL, Jan. 07, 2022 (GLOBE NEWSWIRE) — Branded Legacy, Inc. (OTCQB: BLEG), a holding company focused on the commercial development of hemp and cannabinoid-infused beverages, along with an array of CBD topicals and tinctures adds three new regional managers and opens a new retail account. The Company is starting off 2022 with a strategy focused on sales and revenue growth. President of Branded Legacy, Brandon White, has tapped into his professional network to identify qualified professionals to grow sales in three distinct markets. These new regional managers will be operating in South Florida, North Florida and Michigan and have a focus on both brands with a diverse target market from small retail shops to wholesale and distribution partners. Spikes CBDX opens new retail account,...

Continue reading

Liquidia Re-Finances Debt Facility With Silicon Valley Bank To Increase To $40.0 Million

MORRISVILLE, N.C., Jan. 07, 2022 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) announced today the closing of a debt facility on January 7, 2022, with Silicon Valley Bank (SVB) which provides Liquidia with up to $40.0 million in term loans of which the first $20.0 million was funded at closing. Liquidia initially entered a debt facility with SVB in March 2021 that provided up to $20.5 million in term loans of which $10.5 million had been funded to date. Under the terms of the new debt facility, SVB will make loans available in three tranches. Proceeds from the first tranche of $20.0 million have been used to retire Liquidia’s existing SVB term debt and adds $9.5 million of cash to Liquidia’s balance sheet. The first tranche also provides the option of drawing an additional $5.0 million at Liquidia’s discretion through...

Continue reading

Icelandair: New Chief Customer Officer and Chief Digital Officer appointed

Sylvia Olafsdottir has been appointed Chief Customer Officer and Rakel Ottarsdottir has been appointed Chief Digital Officer of Icelandair Group. They will both take seats on the Executive Committee and will start in the first quarter of the year. These new appointments are part of aligning the Company’s organizational structure to execute its ambitious strategy of sustainable growth, digital transformation and central focus on customer experience. Sylvia rejoins Icelandair Group from the technology company Origo where she has served as Managing Director of Business Development and Marketing for the past year. Sylvia first joined Icelandair in 2018 and served as Director of Operations Support and later as Director of Network Planning & Scheduling. She worked at the energy company Landsvirkjun from 2015 as the Head of its Geothermal...

Continue reading

Milestone Scientific to Present at the H.C. Wainwright BioConnect 2022 Conference

ROSELAND, N.J., Jan. 07, 2022 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that Arjan Haverhals, Chief Executive Officer of Milestone Scientific, will be presenting at the H.C. Wainwright BioConnect 2022 Conference being held virtually January 10-13, 2022. Milestone’s presentation will be available on-demand to registered attendees via the conference platform beginning Monday, January 10, 2022 at 7:00 AM Eastern Time. The webcast of the Company’s presentation can be accessed here: https://journey.ct.events/view/d3b75f3c-73e8-45e2-9fc6-d8c0229c9ed5 and on the investor relations section of the Milestone website at https://www.milestonescientific.com/investors as of 7:00 AM Eastern Time on Monday,...

Continue reading

Icebreaker Botnica charter in summer 2022

Baffinland Iron Mines Corporation (hereinafter: “Baffinland”) declared of using the contractual option to charter the multifunctional icebreaker Botnica in 2022 during the period from the end of June to the end of October. The exact number of chartering days depends on weather and other conditions. In the beginning of summer 2018, the subsidiary company of AS Tallinna Sadam, OÜ TS Shipping, signed an agreement with Baffinland for chartering MPSV Botnica for the 2018 summer period and annual call options for the summer periods in 2019-2022 Baffinland is a Canadian mining company, engaged in the mining of iron ore on Baffin Island in Northern Canada. According to the agreement Botnica provides escort ice management services, oil spill and emergency response services. In the last four years, Botnica assisted Panamax-type cargo vessels in...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.